Efficacy and Safety of MEDI7352 in Subjects with Painful Diabetic Neuropathy

Trial Identifier: D5680C00002
Sponsor: AstraZeneca
NCTID:: NCT03755934
Start Date: November 2018
Primary Completion Date: June 2023
Study Completion Date: June 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Hungarian Translation
Polish Translation
Romanian Translation

Trial Locations

Country Location
DK Gentofte, DK, 2820
ES Girona, ES, 17007
ES Valladolid, ES, 47003
GB Barnsley, GB, S75 3DL
GB Blackpool, GB, FY2 0JH
GB Cannock, GB, WS11 0BN
GB CARDIFF, GB, CF14 4XW
GB Leeds, GB, LS10 1DU
GB London, GB, NW10 7EW
GB Manchester, GB, M13 9NQ
GB Prescot, GB, L34 1BH
GB Stockton-on-Tees, GB, TS17 6EW
HU Balatonfüred, HU, 8230
HU Budapest, HU, 1036
HU Budapest, HU, 1106
HU Győr, HU, 9024
HU Gyula, HU, 5700
PL Bydgoszcz, PL, 85-065
PL Gdańsk, PL, 80-382
PL Katowice, PL, 40-040
PL Katowice, PL, 40-282
PL Kraków, PL, 30-534
PL Lublin, PL, 20-093
PL Lublin, PL, 20064
PL Olsztyn, PL, 10117
PL Poznań, PL, 60-702
PL Rzeszow, PL, 35-302
PL Sochaczew, PL, 96-500
PL Toruń, PL, 87100
PL Warszawa, PL, 00-874
PL Warszawa, PL, 01144
PL Warszawa, PL, 01-192
PL Wrocław, PL, 53-413
RO Bucharest, RO, 020614
RO Bucuresti, RO, 022441
RO Bucuresti, RO, 020475
RO Bucuresti, RO, 011025
RO Calarasi, RO, 917080
RO Craiova, RO, 200505
RO Galati, RO, 800001
RO Galati, RO, 800291
RO Ploiesti, RO, 107400
RO Targu-Mures, RO, 540142